Skip to Main Content
Try STAT+ TODAY
Trending:
Coronavirus
First Opinion
Biotech
Health
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Health Tech
STAT+

‘More Amazon and less pharmacy’: one exec on the company’s strategy for prescription drugs

  • Kate Sheridan

By Kate Sheridan May 12, 2021

Reprints
TJ Parker
TJ Parker, the vice president of pharmacy at Amazon. STAT

Amazon’s objectives for its nascent pharmacy business are straightforward: “better selection, better convenience, and better prices,” according to TJ Parker, the vice president of pharmacy at the company.

“It really is the Amazon playbook,” he said during a Wednesday panel at STAT’s Health Tech Summit.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Kate Sheridan

Kate Sheridan

Research Reporter

Kate collects and analyzes documents, data, and other information for biotech, health tech, science, and politics stories.

Tags

Trending
Eli Lilly headquarters
FDA approves Lilly diabetes drug that analysts expect to…
FDA approves Lilly diabetes drug that analysts expect to be a big seller
nurse RaDonda Vaught
The case of RaDonda Vaught highlights a double standard…
The case of RaDonda Vaught highlights a double standard for nurses and physicians
What the current spike in Covid-19 cases could say…
What the current spike in Covid-19 cases could say about the coronavirus’ future
Recommended
Senate FDA legislation will include dietary supplement, cosmetic reforms
Senate FDA legislation will include dietary supplement, cosmetic reforms
Pharmalot Coming/Going STILL
Up and down the ladder: The latest comings and…
Up and down the ladder: The latest comings and goings
Pharmalittle: Aspen may close South Africa Covid vaccine plant…
Pharmalittle: Aspen may close South Africa Covid vaccine plant due to lack of orders; Roche insists…

Recommended Stories

A headshot of Greg Corrado, who is leading health AI efforts at Google
Health Tech

Humility over hype: An AI leader at Google lays out a vision to transform medical care

By Casey Ross

Rachel Haurwitz of Caribou Biosciences
Biotech

A Caribou CAR-T treatment, backed by Nobel-winning science, shows blood-cancer remissions in first data reveal

By Adam Feuerstein

Roche HQ
Biotech

Roche anti-TIGIT cancer immunotherapy fails second clinical trial, raising doubts about drug class

By Adam Feuerstein

Biotech

A new biotech investment firm, headed by a pair of noteworthy VCs, seeks to ‘free the founders’

By Allison DeAngelis

Special Report

From burst bubble to medical marvel: How lipid nanoparticles became the future of gene therapy

By Megan Molteni